Charles River Laboratories | CRL - Trade Debtors


Charles River Laboratories reported $711.76M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Agilent USD 1.5B 23M Mar/2026
Align Technology USD 1.15B 23.28M Jun/2026
Bio-Rad Laboratories USD 441.8M 15.6M Jun/2026
Bruker USD 545.9M 3.2M Jun/2026
Cardinal Health USD 13.65B 14M Mar/2026
Charles River Laboratories USD 711.76M 11.5M Jun/2026
Cigna USD 30.8B 4.19B Jun/2026
Concord Medical Services Hldg CNY 44.05M 13.31M Dec/2025
CVS Health USD 40.31B 683M Jun/2026
Danaher USD 4.96B 205M Jun/2026
Dentsply International USD 620M 2M Jun/2026
Elevance Health USD 23.39B 602M Jun/2026
Humana USD 5.7B 477M Jun/2026
Illumina USD 764M 26M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
Intrexon USD 1.02M 559K Jun/2024
IQVIA Holdings USD 3.39B 12M Jun/2026
Laboratory Of America USD 2.5B 54.3M Jun/2026
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Lonza CHF 1.78B 55M Dec/2025
McKesson USD 30.32B 2.33B Jun/2026
Merck EUR 4.81B 373M Mar/2026
Mettler Toledo International USD 731.48M 23.27M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Quest Diagnostics USD 1.67B 79M Jun/2026
Revvity USD 709.18M 17.79M Jun/2026
Thermo Fisher Scientific USD 9.45B 247M Jun/2026
United Therapeutics USD 310.3M 1.7M Jun/2026
UnitedHealth USD 21.57B 5.01B Jun/2026
Veradigm USD 175.72M 58.76M Dec/2022
Waters USD 1.99B 228M Jun/2026
West Pharmaceutical Services USD 712M 26.4M Jun/2026